Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marie-Eve Higgins"'
Autor:
Chloé David, Sonia Deschêches, Bertrand Bouchard, Isabelle Robillard, Yan Fen Shi, Marie‐Eve Higgins, Jean‐Claude Tardif, Matthieu Ruiz
Publikováno v:
The FASEB Journal. 36
Autor:
Charlotte Burelle, Sonia Deschênes, Alexanne Cuillerier, Marine De Loof, Marie‐Eve Higgins, Marie‐Elaine Clavet, Caroline Daneault, Martin Sirois, Yan Burelle, Matthieu Ruiz
Publikováno v:
The FASEB Journal. 36
Autor:
Charlotte Burelle, Valentin Clapatiuc, Sonia Deschênes, Alexanne Cuillerier, Marine De Loof, Marie-Ève Higgins, Hugues Boël, Caroline Daneault, Billie Chouinard, Marie-Élaine Clavet, Nolwenn Tessier, Isabelle Croteau, Geneviève Chabot, Catherine Martel, Martin G. Sirois, Sylvie Lesage, Yan Burelle, Matthieu Ruiz
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-19 (2024)
Abstract Lean patients with NAFLD may develop cardiac complications independently of pre-existent metabolic disruptions and comorbidities. To address the underlying mechanisms independent of the development of obesity, we used a murine model of hepat
Externí odkaz:
https://doaj.org/article/88f52e0afd2145fc82e7f585470ab99c
Autor:
Pauline Labbé, Cécile Martel, Yan-Fen Shi, Augusto Montezano, Ying He, Marc-Antoine Gillis, Marie-Ève Higgins, Louis Villeneuve, Rhian Touyz, Jean-Claude Tardif, Nathalie Thorin-Trescases, Eric Thorin
Publikováno v:
Frontiers in Physiology, Vol 15 (2024)
Background: Angiopoietin-like 2 (ANGPTL2) is a pro-inflammatory and pro-oxidant circulating protein that predicts and promotes chronic inflammatory diseases such as atherosclerosis in humans. Transgenic murine models demonstrated the deleterious role
Externí odkaz:
https://doaj.org/article/19430de4480f405aba961fc4a3b79862
Autor:
Yohann Rautureau, Vanessa Deschambault, Geneviève Brand, Marie-Eve Higgins, Mélanie Mecteau, Kurunradeth Uy, Daniel Rivas, Samaneh Samami, Gaétan Mayer, Eric Rhéaume, Jean-Claude Tardif
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 37
Polymorphisms in the ADCY9 gene, coding for adenylate cyclase type 9, determine atherosclerotic cardiovascular responses to the CETP inhibitor dalcetrapib in patients. ADCY9 is broadly expressed and involved in various immune cell functions and infla